Gossamer Bio, Inc.
GOSS
$2.00
-$0.04-1.96%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -51.24M | -56.53M | -71.65M | -80.85M | -172.58M |
| Total Depreciation and Amortization | 3.51M | 4.15M | 4.08M | 4.07M | 4.23M |
| Total Amortization of Deferred Charges | 1.03M | 1.09M | 1.16M | 1.25M | 1.26M |
| Total Other Non-Cash Items | 5.02M | 8.36M | 19.03M | 21.56M | 26.26M |
| Change in Net Operating Assets | 50.79M | 39.46M | 45.97M | 50.10M | -17.65M |
| Cash from Operations | 9.11M | -3.47M | -1.41M | -3.87M | -158.47M |
| Capital Expenditure | -26.00K | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -10.56M | 29.02M | -38.56M | -130.07M | -58.02M |
| Cash from Investing | -10.59M | 29.02M | -38.56M | -130.07M | -58.02M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -9.68M | -12.58M | -15.48M | -18.39M | -11.61M |
| Issuance of Common Stock | 785.00K | 629.00K | 629.00K | 201.75M | 201.75M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 464.00K | 464.00K | 464.00K | 464.00K | -- |
| Cash from Financing | -8.43M | -11.49M | -14.39M | 183.83M | 190.14M |
| Foreign Exchange rate Adjustments | 65.00K | -102.00K | 216.00K | -13.00K | -24.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -9.84M | 13.97M | -54.15M | 49.87M | -26.38M |